Vision Medicines
A Team of Proven Executives, Seasoned Clinical Developers and Prominent Thought Leaders Caring About Patients Whose Blinding Diseases Have Limited or No Treatment Options Developing Differentiated Medicines for Orphan and Retinal Diseases with Unmet Medical Needs

Vision Medicines is a biopharmaceutical company focused on greatly improving the lives of patients suffering from rare diseases, particularly those involving the retina, where there are no treatments. Our lead drug candidate is a promising treatment for Stargardt disease, a rare genetic retinal degenerative disease that leads to legal blindness. It also has the potential to treat other rare diseases caused by inborn errors of aldehyde metabolism.

Investors & Media Relations:


Business Development: